Page last updated: 2024-10-24

verapamil and Neuromuscular Diseases

verapamil has been researched along with Neuromuscular Diseases in 2 studies

Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.

Neuromuscular Diseases: A general term encompassing lower MOTOR NEURON DISEASE; PERIPHERAL NERVOUS SYSTEM DISEASES; and certain MUSCULAR DISEASES. Manifestations include MUSCLE WEAKNESS; FASCICULATION; muscle ATROPHY; SPASM; MYOKYMIA; MUSCLE HYPERTONIA, myalgias, and MUSCLE HYPOTONIA.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Factor, SM1
Minase, T1
Cho, S1
Dominitz, R1
Sonnenblick, EH1
Lang, B1
Newsom-Davis, J1
Wray, DW1

Other Studies

2 other studies available for verapamil and Neuromuscular Diseases

ArticleYear
Microvascular spasm in the cardiomyopathic Syrian hamster: a preventable cause of focal myocardial necrosis.
    Circulation, 1982, Volume: 66, Issue:2

    Topics: Animals; Cardiomyopathies; Coronary Circulation; Cricetinae; Mesocricetus; Microcirculation; Muscle,

1982
The effect of Lambert-Eaton myasthenic syndrome antibody on slow action potentials in mouse cardiac ventricle.
    Proceedings of the Royal Society of London. Series B, Biological sciences, 1988, Oct-22, Volume: 235, Issue:1278

    Topics: 4-Aminopyridine; Action Potentials; Aminopyridines; Animals; Calcium Channels; Heart; Heart Ventricl

1988